Quantcast

ST. LOUIS RECORD

Monday, May 20, 2024

News from May 2023


Top prosecutor facing 'indirect criminal contempt of court' proceedings, potential jail time

By Juliette Fairley |
Assistant prosecutor Chris Desilets resigned May 1

Florida toxicologist used to bolster IARC finding of Roundup as carcinogen in Roundup trial

By John Sammon |
Attorneys debated the accuracy of a 2015 finding that glyphosate in the Monsanto weed killer Roundup causes cancer in humans

Thompson Coburn announces Recognized as the most philanthropic midsize company in St. Louis for second year in a row

By St. Louis Record Report |
Thompson Coburn was selected as the first-place honoree for midsize companies in the St. Louis Business Journal’s 2023 Corporate Philanthropy Awards.

TRO granted against AG Bailey's transgender-affirming healthcare restrictions

By Juliette Fairley |
Gays Against Groomers: 'The judge is endangering confused gay kids'

Sister of teen who committed suicide sues incarcerated stepfather alleging sexual abuse

By Juliette Fairley |
Melissa Hogg, 24, sued her stepfather Charles Haynes who is currently incarcerated

Daughter recounts agony of mother’s cancer treatments in Monsanto Roundup trial

By John Sammon |
The daughter of plaintiff Sharlean Gordon said her mother’s treatments for cancer and resulting anxiety became like a nightmare for her and the members of her family in a Monsanto Roundup trial

Armstrong Teasdale announces Adds Lawyers in St. Louis, New York, Washington, D.C., Denver

By St. Louis Record Report |
Armstrong Teasdale announces the addition of Partner Elizabeth S. Silker to the firm’s St. Louis office, Senior Associate Natasa Saciri to the New York office, and Associates Taylor A. Green and Keyur Parikh to the Washington, D.C., and Denver offices, respectively.

Epidemiologist tells jury in Missouri Monsanto Roundup trial defense attorney statistics off-base

By John Sammon |
In a lawsuit launched by a woman claiming the weed killer Roundup caused her cancer attorneys sparred on Friday over whether cases of non-Hodgkin’s lymphoma went up alongside a big increase in use of the product.